PharmaShots | Incisive News in 3 Shots

Subscribe Now

Pharma

Sanofi Licenses an Undisclosed Nurix Therapeutics’ Drug Program for Autoimmune Diseases

Sanofi Licenses an Undisclosed Nurix Therapeutics’ Drug Program for Autoimmune Diseases

April 3, 2025

Reuters Pharma 2025: Pre-Conference Talks Featuring Vikram Mohan

Reuters Pharma 2025: Pre-Conference Talks Featuring Vikram Mohan

April 2, 2025

Ono Enters into an Option Agreement with Reborna Biosciences for RNA-Targeting Small Molecule to treat CNS Disorders

Ono Enters into an Option Agreement with Reborna Biosciences for RNA-Targeting Small Molecule to treat CNS Disorders

April 1, 2025

Lexicon Enters a Global Licensing Agreement with Novo Nordisk for LX9851

Lexicon Enters a Global Licensing Agreement with Novo Nordisk for LX9851

March 31, 2025

PharmaShots Weekly Snapshots (March 24, 2025 – March 28, 2025)

PharmaShots Weekly Snapshots (March 24, 2025 – March 28, 2025) 

March 28, 2025

Ionis Partners with Sobi for Olezarsen to Treat Familial Chylomicronemia Syndrome (FCS) & Severely Elevated Triglycerides

Ionis Partners with Sobi for Olezarsen to Treat Familial Chylomicronemia Syndrome (FCS) & Severely Elevated Triglycerides

March 27, 2025

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us